JSE

4 September 2025

Discover the Discovery Profit Surge with profits up to 32%. Learn about the financial results and profitability milestones reached.

24 August 2025

Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?

24 August 2025

Adcock Ingram reports steady annual profits as winter demand for Panado and Corenza-C drives growth in the second half.

12 August 2025

Discover the impressive rise of Clicks value as it nears R100 billion, outpacing Dis-Chem in market valuation.

11 August 2025

Life Healthcare announces a special cash dividend following the successful R13.9 billion sale of its LMI division.

30 July 2025

Learn how Bidvest's partnership with Natco Pharma impacts Adcock Ingram and shareholder rights amid a new takeover bid.

24 July 2025

Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.

4 July 2025

The group identifies limited availability of profitable locations as a key risk to its expansion strategy, which relies on opening new stores and acquiring independent pharmacies.

29 June 2025

Explore the potential returns of investing in hospitals and the impact on healthcare innovation and access.

29 June 2025

Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.

29 June 2025

Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.

Search the archive

Browse by month